Results 211 to 220 of about 269,227 (256)

Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective

International Journal of Molecular Sciences, 2021
Chiara Brullo, Andrea Spallarossa, Carla Villa   +2 more
exaly  

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy

Cancers, 2020
Nor Eddine Sounni, Charles Pottier, Guy Jerusalem   +2 more
exaly  

Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials

Journal of Xenobiotics, 2023
Wajeeha Aiman, Mohammad Hamza, Zainab T O Omar   +2 more
exaly  

The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020

Bioorganic Chemistry, 2021
, Zhongyin Yin, Lizi Yin
exaly  

The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?

International Journal of Molecular Sciences, 2021
Joanna Zawitkowska, Monika Lejman, Agnieszka Kaczmarska   +2 more
exaly  

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer Treatment Reviews, 2009
Hans Gelderblom, Nielka Van Erp
exaly  

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?

Trends in Endocrinology and Metabolism, 2015
Athanasios Fountas, Agathocles Tsatsoulis   +1 more
exaly  

Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer

Cancer Treatment Reviews, 2018
Sibylle Loibl, Jacek Jassem, Renata Duchnowska   +2 more
exaly  

Tyrosine kinase inhibitors

2001
FRALEY MARK E, HAMBAUGH SCOTT R, HUNGATE RANDALL W   +2 more
openaire   +9 more sources

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis

Cancer Treatment Reviews, 2013
Han Kiat Ho
exaly